文献速递其他结缔组织病

职业治疗改善早期系统性硬化症患者上肢功能:一项初步研究

Occupational Therapy Treatment to Improve Upper Extremity Function in Individuals with Early Systemic Sclerosis: A Pilot Study.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2018-01-01

在密歇根大学硬皮病中心开展的单组初步康复临床试验,纳入21例伴至少1个上肢挛缩的早期系统性硬化症患者,接受8次每周面对面职业治疗。8周时QuickDASH和PROMIS身体功能均显著改善(P=0.0012和P=0.004),约半数患者改善超过最小重要差异。

要点

  • 21例早期弥漫性系统性硬化症伴上肢挛缩患者完成8次每周职业治疗。
  • 8周时QuickDASH和PROMIS身体功能显著改善,P值分别为0.0012和0.004。
  • 约半数患者QuickDASH和PROMIS改善超过最小重要差异。

核心结论

  • 面对面治疗在系统性硬化症患者中可行,并带来上肢和身体功能具有统计学显著性和临床意义的改善。
  • 作者认为未来研究应将系统性硬化症的影响与对照条件比较,并检验治疗效果的持久性。

研究设计与样本

  • 在密歇根大学硬皮病中心开展的单组初步临床康复试验。
  • 纳入21例伴至少1个上肢挛缩的系统性硬化症患者,参加共8次每周面对面职业治疗。
  • 治疗包括热疗、组织松动和上肢活动度练习,并要求患者在两次治疗间在家进行上肢练习。
  • 可行性通过入组百分比、治疗出席率和治疗时长衡量。
  • 主要结局为简化上肢、肩和手功能障碍量表(QuickDASH),次要和探索性结局包括PROMIS身体功能测量、上肢活动度、力量和协调性的客观测量以及皮肤增厚。

主要发现

  • 48例潜在合格受试者中24例(50%)有兴趣参与,24例中21例(88%)入组,21例中19例(91%)完成所有治疗。
  • 参与者平均年龄47.9±16.1岁,100%为弥漫性系统性硬化症,平均病程3.1年。
  • 8周时QuickDASH和PROMIS身体功能测量均出现统计学显著改善,P值分别为0.0012和P=0.004。
  • 样本中约一半参与者的QuickDASH和PROMIS测量改善超过最小重要差异。

关键数值与推荐

  • 可行性:48例潜在合格受试者中24例(50%)有兴趣参与,24例中21例(88%)入组,21例中19例(91%)完成所有治疗。
  • 主要结局:8周时QuickDASH改善具有统计学显著性,P=0.0012。
  • 次要结局:8周时PROMIS身体功能测量改善具有统计学显著性,P=0.004。
  • 约一半参与者的QuickDASH和PROMIS测量改善超过最小重要差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文指出未来研究应将系统性硬化症的影响与对照条件比较。
  • 原文指出未来研究应检验治疗效果的持久性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the feasibility and preliminary effects of occupational therapy to improve upper extremity function in patients with early systemic sclerosis (SSc; scleroderma) who have upper extremity contractures. METHODS: A single-group pilot clinical rehabilitation trial was conducted at the University of Michigan Scleroderma Center. Patients with SSc and ≥1 upper extremity contracture (n = 21) participated in a total of 8 weekly in-person occupational therapy sessions. The therapy consisted of thermal modalities, tissue mobilization, and upper extremity mobility exercises. The participants were instructed to perform upper extremity exercises at home between sessions. Feasibility was measured by the percent enrollment as well as session attendance and session duration. The primary outcome measure was the Shortened Disabilities of the Arm, Shoulder and Hand measure (QuickDASH); secondary and exploratory outcomes included the Patient-Reported Outcomes Measurement Information System (PROMIS) physical function measures; objective measures of upper extremity mobility, strength, and coordination; and skin thickening. Linear mixed models were used to determine the effects of treatment on the primary and secondary outcomes. RESULTS: Fifty percent of potentially eligible subjects (24 of 48) were interested in participating. Twenty-one (88%) of the 24 subjects were enrolled, and 19 (91%) of these 21 subjects completed all sessions. The mean ± SD age of the participants was 47.9 ± 16.1 years; 100% had diffuse SSc, and the mean disease duration was 3.1 years. At 8 weeks, participants had statistically significant improvement in the QuickDASH and PROMIS physical function measure (P = 0.0012 and P = 0.004, respectively). Approximately one-half of participants in the sample achieved improvement in the QuickDASH and PROMIS measure that exceeded minimally important differences. CONCLUSION: In-person treatment sessions were feasible in the patients with SSc and resulted in statistically significant and clinically meaningful improvements in upper extremity and physical function. In future studies, the effects of SSc should be compared with those in a control condition, and the durability of treatment effects should be examined.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Murphy SL, Barber MW, Homer K, et al. Occupational Therapy Treatment to Improve Upper Extremity Function in Individuals with Early Systemic Sclerosis: A Pilot Study. Arthritis Care Res (Hoboken). 2018. PMID: 29381834. doi:10.1002/acr.23522

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。